Sal Guccione is Executive Chairman of The Emmes Company, LLC, a clinical stage contract research organization advancing pharmaceutical and public health research.
He is also an Executive Advisor to New Mountain Capital, LLC and a Director of Aceto Corporation, a New Mountain-backed manufacturer and supplier of products for life sciences and other markets. Mr. Guccione brings more than 30 years of leadership experience, including CEO, CFO and strategic planning/M&A in the pharmaceutical, biotechnology and specialty chemical ingredients industries. He was President and Chief Executive Officer of Aceto Corporation until 2017. Prior to that, he was CEO of WIL Research Laboratories, a contract research organization for the pharmaceutical industry. Mr. Guccione was also Executive Vice President, Strategy, Chief Financial Officer and Vice President, Corporate Development of Cambrex Corporation, a leading active pharmaceutical ingredients company and CDMO. Prior to that, he was Vice President, General Manager of ISP Personal Care Ingredients, a global developer, manufacturer and marketer of specialty chemical ingredients for the personal care industry.
Mr. Guccione holds a Bachelor of Science degree in chemical engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business.
This person is not in the org chart
This person is not in any teams